ADLVX | VMVAX | ADLVX / VMVAX | |
Total Expense Ratio | 1.33 | 0.07 | 1,900% |
Annual Report Gross Expense Ratio | 6.23 | 0.07 | 8,900% |
Fund Existence | 7 years | 14 years | - |
Gain YTD | 2.433 | -1.683 | -145% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 3000 | 83% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 3.89M | 29.1B | 0% |
Annual Yield % from dividends | 1.43 | 2.40 | 60% |
Returns for 1 year | 5.80 | 3.48 | 167% |
Returns for 3 years | 11.11 | 15.55 | 71% |
Returns for 5 years | 68.56 | 76.40 | 90% |
Returns for 10 years | N/A | 75.65 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
NVD | 24.16 | 0.31 | +1.30% |
GraniteShares 2x Short NVDA Daily ETF | |||
PP | 26.10 | N/A | N/A |
Meet Kevin Pricing Power ETF (The) | |||
NOBL | 98.43 | -0.19 | -0.20% |
ProShares S&P 500 Dividend Aristocrats | |||
SEIQ | 35.00 | -0.17 | -0.47% |
SEI Enhanced US Large Cap Qual Fac ETF | |||
ARKG | 21.13 | -0.60 | -2.76% |
ARK Genomic Revolution ETF |